Related Experiment Video
Updated: Jun 7, 2026
11:03
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
Advances in hepatobiliary pathology: update for 2010.
1Department of Pathology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street-PH 15 West, Room 1574, New York, NY 10032, USA. jhl3@columbia.edu
Clinics in Liver Disease
|November 9, 2010
Summary
Recent hepatology publications cover liver diseases like viral hepatitis, autoimmune hepatitis, and nonalcoholic fatty liver disease. Advances in diagnosing primary biliary cirrhosis, sclerosing cholangitis, and IgG4-related conditions are also detailed.
Area of Science:
- Hepatology and Hepatic Pathology
- Gastroenterology
- Oncology
Background:
- Recent literature offers new insights into diverse liver conditions.
- Key areas include viral hepatitis (B and C), autoimmune hepatitis, and HIV-associated liver disease.
- Nonalcoholic fatty liver disease remains a prevalent concern.
Purpose of the Study:
- To summarize recent advancements in the understanding and diagnosis of various liver diseases.
- To highlight the role of immunohistochemistry in differentiating benign and malignant liver tumors.
- To review the morphologic, diagnostic, and pathogenetic aspects of key hepatobiliary disorders.
Main Methods:
- Review of recent publications in hepatology and hepatic pathology.
- Analysis of morphologic features in viral, autoimmune, and HIV-related liver diseases.
- Examination of diagnostic and pathogenetic data for primary biliary cirrhosis, primary sclerosing cholangitis, and IgG4 hepatobiliary diseases.
- Histologic and immunohistochemical evaluation of liver tumors, including calcifying nested stromal-epithelial tumor.
Main Results:
- Detailed descriptions of morphologic aspects of common and rare liver diseases.
- Advances in the diagnosis and pathogenesis of cholestatic and IgG4-related hepatobiliary diseases.
- Demonstration of immunohistochemistry's crucial role in distinguishing liver-cell adenoma from focal nodular hyperplasia.
Conclusions:
- The field of hepatology is rapidly evolving with new diagnostic and pathogenetic insights.
- Immunohistochemistry is indispensable for accurate liver tumor diagnosis.
- Comprehensive understanding of liver pathology aids in managing diverse hepatobiliary conditions.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...